SEVEN GRADUATES WHO MAKE ESG UQAM PROUD

Réseau ESG UQAM will salute the brilliant careers of seven graduates of UQAM’s École des sciences de la gestion (ESG UQAM) on November 18 at its annual Prix Performance Gala. Under the honorary chairmanship of Sylvain Roy (B.A.A. 91), President of Rogers Québec, the event will take place in the Salle Le Parquet at Centre…

Mario Chevrette appointed Vice President, Scientific Affairs of CQDM

Montreal, September 2, 2014. – The President and CEO of CQDM, Diane Gosselin, is pleased to announce the appointment of Mario Chevrette as Vice President, Scientific Affairs effective September 2, 2014. Mr. Chevrette will be responsible for all CQDM scientific affairs. More specifically, he will play a key role in managing funding programs and projects,…

CQDM and OCE co-fund a promising research collaboration in neuroscience

Toxicity assessment by fluorescence and luminescencePhoto credit: Xiao-Yan Wen Toronto, August 19, 2014 – CQDM and Ontario Centres of Excellence (OCE) are pleased to announce the funding of a new collaborative, inter-provincial project that could accelerate clinical development of treatment for neurodegenerative diseases such as Alzheimer’s, Parkinson’s, Amyotrophic Lateral Sclerosis, and diabetes. As part of the Quebec-Ontario Life…

We are RECRUITING! Interested in a Controller position? Apply now!

From left to right: Michele Davies, Director, Partnerships Development at OCE, Diane Gosselin, President and CEO at CQDM, Jacques Daoust, Quebec Minister of Economy, Innovation and Exports and John Clarkson, Senior Vice-President at OBI San Diego, June 23rd, 2014. – Ontario Centres of Excellence (OCE) and the Ontario Brain Institute (OBI) are partnering with CQDM to bring an additional $3 million to two programs…

CQDM and Sanofi Canada partner to accelerate drug discovery

From left to right : Léon Gosselin, Chairman of CQDM’s Board of Directors; Marc Bonnefoi, the North America Head of R&D at Sanofi; Diane Gosselin, President and CEO of CQDM; Jon Fairest, President and CEO of Sanofi Canada and Franca Mancino, Sanofi Canada’s VP of Medical and Regulatory Affairs CQDM and Sanofi Canada are pleased to announce…

Outside the box in neuroscience: CQDM and Brain Canada partner to fund breakthrough technologies to accelerate drug discovery

From left to right : Diane Gosselin, President and CEO of CQDM, Rémi Quirion, Quebec’s Chief Scientist, Samuel David, President of the Canadian Association for Neuroscience and Inez Jabalpurwala, President and CEO of Brain Canada CQDM and Brain Canada launched a new funding program that will provide at least $10 million to support the development of innovative tools, technologies and platforms to accelerate…